Overview

A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

Status:
Active, not recruiting
Trial end date:
2024-08-21
Target enrollment:
Participant gender:
Summary
To assess the long term safety and efficacy of treatment with BI 655130 in patients with AD who have completed and have responded to treatment in the parent study 1368-0032
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim